FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046427955> ?p ?o ?g. }

• W2046427955 endingPage "e78881" @default.
• W2046427955 startingPage "e78881" @default.
• W2046427955 abstract "Cabozantinib is an inhibitor of multiple receptor tyrosine kinases, including MET and VEGFR2. In a phase II clinical trial in advanced prostate cancer (PCa), cabozantinib treatment improved bone scans in 68% of evaluable patients. Our studies aimed to determine the expression of cabozantinib targets during PCa progression and to evaluate its efficacy in hormone-sensitive and castration-resistant PCa in preclinical models while delineating its effects on tumor and bone. Using immunohistochemistry and tissue microarrays containing normal prostate, primary PCa, and soft tissue and bone metastases, our data show that levels of MET, P-MET, and VEGFR2 are increasing during PCa progression. Our data also show that the expression of cabozantinib targets are particularly pronounced in bone metastases. To evaluate cabozantinib efficacy on PCa growth in the bone environment and in soft tissues we used androgen-sensitive LuCaP 23.1 and castration-resistant C4-2B PCa tumors. In vivo, cabozantinib inhibited the growth of PCa in bone as well as growth of subcutaneous tumors. Furthermore, cabozantinib treatment attenuated the bone response to the tumor and resulted in increased normal bone volume. In summary, the expression pattern of cabozantinib targets in primary and castration-resistant metastatic PCa, and its efficacy in two different models of PCa suggest that this agent has a strong potential for the effective treatment of PCa at different stages of the disease." @default.
• W2046427955 created "2016-06-24" @default.
• W2046427955 creator A5002466627 @default.
• W2046427955 creator A5014047283 @default.
• W2046427955 creator A5018745405 @default.
• W2046427955 creator A5033109323 @default.
• W2046427955 creator A5035481357 @default.
• W2046427955 creator A5044591528 @default.
• W2046427955 creator A5047140847 @default.
• W2046427955 creator A5054043060 @default.
• W2046427955 creator A5057037633 @default.
• W2046427955 creator A5070847041 @default.
• W2046427955 creator A5088583553 @default.
• W2046427955 date "2013-10-25" @default.
• W2046427955 modified "2023-10-13" @default.
• W2046427955 title "Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling" @default.
• W2046427955 cites W1263532934 @default.
• W2046427955 cites W1520841340 @default.
• W2046427955 cites W1557061959 @default.
• W2046427955 cites W1562931024 @default.
• W2046427955 cites W1761343402 @default.
• W2046427955 cites W1963529046 @default.
• W2046427955 cites W1970181198 @default.
• W2046427955 cites W1977999028 @default.
• W2046427955 cites W1991355732 @default.
• W2046427955 cites W2006124032 @default.
• W2046427955 cites W2018307268 @default.
• W2046427955 cites W2023479969 @default.
• W2046427955 cites W2026652849 @default.
• W2046427955 cites W2028115229 @default.
• W2046427955 cites W2050309608 @default.
• W2046427955 cites W2054633892 @default.
• W2046427955 cites W2060963893 @default.
• W2046427955 cites W2100370551 @default.
• W2046427955 cites W2100945326 @default.
• W2046427955 cites W2101918466 @default.
• W2046427955 cites W2102497054 @default.
• W2046427955 cites W2105293913 @default.
• W2046427955 cites W2112388362 @default.
• W2046427955 cites W2116485788 @default.
• W2046427955 cites W2120795894 @default.
• W2046427955 cites W2121076737 @default.
• W2046427955 cites W2130040381 @default.
• W2046427955 cites W2132051411 @default.
• W2046427955 cites W2136146667 @default.
• W2046427955 cites W2144700396 @default.
• W2046427955 cites W2146465225 @default.
• W2046427955 cites W2147313109 @default.
• W2046427955 cites W2158011521 @default.
• W2046427955 cites W2158298823 @default.
• W2046427955 cites W2163029804 @default.
• W2046427955 cites W2167780425 @default.
• W2046427955 cites W2170476872 @default.
• W2046427955 doi "https://doi.org/10.1371/journal.pone.0078881" @default.
• W2046427955 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3808282" @default.
• W2046427955 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24205338" @default.
• W2046427955 hasPublicationYear "2013" @default.
• W2046427955 type Work @default.
• W2046427955 sameAs 2046427955 @default.
• W2046427955 citedByCount "58" @default.
• W2046427955 countsByYear W20464279552014 @default.
• W2046427955 countsByYear W20464279552015 @default.
• W2046427955 countsByYear W20464279552016 @default.
• W2046427955 countsByYear W20464279552017 @default.
• W2046427955 countsByYear W20464279552018 @default.
• W2046427955 countsByYear W20464279552019 @default.
• W2046427955 countsByYear W20464279552020 @default.
• W2046427955 countsByYear W20464279552021 @default.
• W2046427955 countsByYear W20464279552022 @default.
• W2046427955 countsByYear W20464279552023 @default.
• W2046427955 crossrefType "journal-article" @default.
• W2046427955 hasAuthorship W2046427955A5002466627 @default.
• W2046427955 hasAuthorship W2046427955A5014047283 @default.
• W2046427955 hasAuthorship W2046427955A5018745405 @default.
• W2046427955 hasAuthorship W2046427955A5033109323 @default.
• W2046427955 hasAuthorship W2046427955A5035481357 @default.
• W2046427955 hasAuthorship W2046427955A5044591528 @default.
• W2046427955 hasAuthorship W2046427955A5047140847 @default.
• W2046427955 hasAuthorship W2046427955A5054043060 @default.
• W2046427955 hasAuthorship W2046427955A5057037633 @default.
• W2046427955 hasAuthorship W2046427955A5070847041 @default.
• W2046427955 hasAuthorship W2046427955A5088583553 @default.
• W2046427955 hasBestOaLocation W20464279551 @default.
• W2046427955 hasConcept C121608353 @default.
• W2046427955 hasConcept C126322002 @default.
• W2046427955 hasConcept C143998085 @default.
• W2046427955 hasConcept C170033053 @default.
• W2046427955 hasConcept C193270364 @default.
• W2046427955 hasConcept C2776235491 @default.
• W2046427955 hasConcept C2777911890 @default.
• W2046427955 hasConcept C2780192828 @default.
• W2046427955 hasConcept C2781064419 @default.
• W2046427955 hasConcept C502942594 @default.
• W2046427955 hasConcept C61367390 @default.
• W2046427955 hasConcept C71315377 @default.
• W2046427955 hasConcept C71924100 @default.
• W2046427955 hasConceptScore W2046427955C121608353 @default.
• W2046427955 hasConceptScore W2046427955C126322002 @default.

• next